The store will not work correctly when cookies are disabled.
2-(Benzo[d][1,3]dioxol-5-ylamino)-3-hydroxynaphthalene-1,4-dione
ID: ALA4524841
PubChem CID: 155538807
Max Phase: Preclinical
Molecular Formula: C17H11NO5
Molecular Weight: 309.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(O)=C(Nc2ccc3c(c2)OCO3)C(=O)c2ccccc21
Standard InChI: InChI=1S/C17H11NO5/c19-15-10-3-1-2-4-11(10)16(20)17(21)14(15)18-9-5-6-12-13(7-9)23-8-22-12/h1-7,18,21H,8H2
Standard InChI Key: GNKANKXFDWDCFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
2.8313 -17.1128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8302 -17.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5448 -18.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5430 -16.7002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2582 -17.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2571 -17.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9699 -18.3504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6883 -17.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6895 -17.1112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9722 -16.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9722 -15.8689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9675 -19.1752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4048 -16.7005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4015 -18.3539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1170 -17.9435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8273 -18.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8269 -16.7120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1148 -17.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5459 -17.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5396 -17.9501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3222 -18.2111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8123 -17.5473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3325 -16.8762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
7 12 2 0
9 13 1 0
8 14 1 0
14 15 1 0
15 16 2 0
16 20 1 0
19 17 1 0
17 18 2 0
18 15 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.28 | Molecular Weight (Monoisotopic): 309.0637 | AlogP: 2.68 | #Rotatable Bonds: 2 |
Polar Surface Area: 84.86 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.28 | CX Basic pKa: ┄ | CX LogP: 1.51 | CX LogD: 0.36 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.89 | Np Likeness Score: -0.15 |
References
1. Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695] [10.1016/j.ejmech.2019.02.018] |